Clinical Trial Update: Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating absorption, metabolism and excretion of [14C] ASP2215 (gilteritinib) in patients with advanced solid tumors; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Gilteritinib (gilteritinib)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Advanced Solid Tumors, Pharmacokinetics of 14C-labeled Gilteritinib | Phase 1 | Status: COMPLETED